98 results on '"Hayney, Mary S."'
Search Results
2. Seroresponse to Inactivated and Recombinant Influenza Vaccines Among Maintenance Hemodialysis Patients
3. High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease
4. Mo1483: LOW PREVALENCE OF SERIOUS INFECTIONS DUE TO VACCINEPREVENTABLE DISEASES IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
5. Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
6. Influenza vaccination rates and location for receiving the influenza vaccination among older adult Medicare beneficiaries
7. 255 RACIAL AND GENDER DISPARITIES EXIST IN INFLUENZA VACCINATION RATES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
8. Fr552 RURAL-DWELLING PATIENTS WITH IBD HAVE LOWER INFLUENZA AND PNEUMOCOCCAL IMMUNIZATION RATES
9. What Gastroenterologists Should Know About COVID-19 Vaccines
10. Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity
11. How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients with Inflammatory Bowel Disease and Chronic Liver Disease
12. Reducing the Risk of Vaccine Preventable Diseases During the COVID-19 Pandemic
13. Timeliness of data entry in Wisconsin Immunization Registry by Wisconsin pharmacies
14. Mo1812 THE BURDEN OF VACCINE-PREVENTABLE INFECTIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
15. Sa1768 A MAJORITY OF YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE HAVE SUSTAINED IMMUNITY TO HEPATITIS B
16. Su1834 ACCURACY OF SELF-REPORTED VACCINATION STATUS IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
17. Zoster vaccine in immunosuppressed populations
18. Cross-sectional study of hepatitis B antibody status in health care workers immunized as children at an academic medical center in Wisconsin
19. Human papillomavirus immunization reduces the burden of disease in the community
20. The strength of the community: Herd protection
21. Understanding the role of vaccination exemption in the recent measles outbreaks
22. Preventing shoulder injury related to vaccine administration
23. Mo1889 – Young Patients with Inflammatory Bowel Disease Have Equivalent Protection Against Herpes Zoster Compared to Healthy Controls for Whom the Herpes Zoster Vaccine is Recommended
24. The Vaccine Injury Compensation Program and the pharmacist’s role in patient education
25. Strategies for responding to vaccine hesitancy and vaccine deniers
26. Elusive eradication: Challenges facing the worldwide eradication of polio
27. Mumps outbreaks: Implementation of a third dose of mumps-containing vaccine
28. 279 - Randomized Trial Evaluating the Immunogenicity of High Dose vs. Standard Dose Influenza Vaccine in IBD Patients on Anti-TNF Monotherapy
29. Mo1882 - Vedolizumab Does not affect Influenza Vaccine Antibody Response
30. Hepatitis A outbreaks
31. Vaccine adjuvants: Key components of some new vaccines
32. Vaccination immune response in obese individuals
33. Recommendations for patients with diabetes
34. Influenza vaccine formulation and effectiveness
35. Serum IFN-γ-induced protein 10 (IP-10) as a biomarker for severity of acute respiratory infection in healthy adults
36. Lower Sustained Pertussis Concentrations in Patients with Inflammatory Bowel Disease on Biologic Therapy
37. Herpes zoster: The changing landscape
38. Pharmacy student involvement with increasing human papillomavirus (HPV) vaccination among international college students
39. The vaccine development process
40. Vaccination of patients with inflammatory bowel disease
41. Strategies to minimize vaccine errors
42. 993 Lower Sustained Antibody Concentrations to Tetanus and Diphtheria Vaccine in Patients With Inflammatory Bowel Disease
43. Addressing vaccine hesitancy in the pharmacy
44. HPV9: Combating HPV-associated cancers by strengthening serotype defenses
45. Adult vaccines for individuals with human immunodeficiency virus infection
46. Recommendation for conjugate pneumococcal and pneumococcal polysaccharide vaccines in adults older than 65 years
47. Immunization information systems: A decade of progress
48. Progress toward vaccines for cholera, dengue, malaria, and Ebola
49. Human papillomavirus: A brief overview and recommendations for pharmacists
50. Inflammatory chronic diseases: Preventable by vaccines?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.